A site-specific genetic modification for induction of pluripotency and subsequent isolation of derived lung alveolar epithelial type II cells

Stem Cells

Volumn 32, Issue 2, 2014, Pages 402-413

  Yan, Qing ^a   Quan, Yuan ^a   Sun, Huanhuan ^a   Peng, Xinmiao ^b   Zou, Zhengyun ^a   Alcorn, Joseph L ^a   Wetsel, Rick A ^a,b   Wang, Dachun ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Differentiation and characterization; Induced pluripotent stem cells; Lung alveolar epithelial type II cells; Site specific targeting strategy

Indexed keywords

DIFFERENTIATION AND CHARACTERIZATION; INDUCED PLURIPOTENT STEM CELLS; LUNG ALVEOLAR EPITHELIAL TYPE II CELLS; SITE-SPECIFIC TARGETING STRATEGY;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INTEGRASES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LUNG; MICE; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; PULMONARY ALVEOLI; SOXB1 TRANSCRIPTION FACTORS;

EID: 84894554620     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1570     Document Type: Article

References (38)

1. Selman M, King TE, Pardo A et al. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134: 136-151.
2. Nogee LM, Garnier G, Dietz HC et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994; 93: 1860-1863.
3. Nogee LM, de Mello DE, Dehner LP et al. Brief report: Deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993;328: 406-410.
4. Hamvas A, Nogee LM, White FV et al. Progressive lung disease and surfactant dysfunction with a deletion in surfactant protein C gene. Am J Respir Cell Mol Biol 2004;30: 771-776.
5. Yamanaka S, Takahashi K. [Induction of pluripotent stem cells from mouse fibroblast cultures]. Tanpakushitsu Kakusan Koso 2006; 51: 2346-2351.
6. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126: 663-676.
7. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920.
8. Kaji K, Norrby K, Paca A et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009;458: 771-775.
9. Stadtfeld M, Nagaya M, Utikal J et al. Induced pluripotent stem cells generated without viral integration. Science 2008; 322: 945-949.
10. Fusaki N, Ban H, Nishiyama A et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 2009;85: 348-362.
11. Jia F, Wilson KD, Sun N et al. A nonviral minicircle vector for deriving human iPS cells. Nat Methods 2010;7: 197-199.
12. Woltjen K, Michael IP, Mohseni P et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009;458: 766-770.
13. Yu J, Hu K, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324: 797-801.
14. Kim D, Kim CH, Moon JI et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009;4: 472-476.
15. Warren L, Manos PD, Ahfeldt T et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010;7: 618-630.
16. Miyoshi N, Ishii H, Nagano H et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 2011;8: 633-638.
17. Zheng B, Mills AA, Bradley A. A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice. Nucleic Acids Res 1999; 27: 2354-2360.
18. Wang D, Haviland DL, Burns AR et al. A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2007;104: 4449-4454.
19. Wernig M, Lengner CJ, Hanna J et al. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 2008;26: 916-924.
20. Wang D, Morales JE, Calame DG et al. Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther 2010;18: 625-634.
21. Alcorn JL, Smith ME, Smith JF et al. Primary cell culture of human type II pneumonocytes: Maintenance of a differentiated phenotype and transfection with recombinant adenoviruses. Am J Respir Cell Mol Biol 1997;17: 672-682.
22. Sano K, Voelker DR, Mason RJ. Effect of secretagogues on cytoplasmic free calcium in alveolar type II epithelial cells. Am J Physiol 1987;253(5 pt 1): C679-C686.
23. Romero EJ, Moya FR, Tuvim MJ et al. Interaction of an artificial surfactant in human pulmonary epithelial cells. Pediatr Pulmonol 2005;39: 167-177.
24. Chen ES, Greenlee BM, Wills-Karp M et al. Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin. Am J Respir Cell Mol Biol 2001;24: 545-555.
25. Kim CF, Jackson EL, Woolfenden AE et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121: 823-835.
26. Kreda SM, Gynn MC, Fenstermacher DA et al. Expression and localization of epithelial aquaporins in the adult human lung. Am J Respir Cell Mol Biol 2001;24: 224-234.
27. Ramirez MI, Millien G, Hinds A et al. T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev Biol 2003;256: 61-72.
28. Vanderbilt JN, Allen L, Gonzalez RF et al. Directed expression of transgenes to alveolar type I cells in the mouse. Am J Respir Cell Mol Biol 2008;39: 253-262.
29. Chen J, Chen Z, Narasaraju T et al. Isolation of highly pure alveolar epithelial type I and type II cells from rat lungs. Lab Invest 2004;84: 727-735.
30. Millien G, Spira A, Hinds A et al. Alterations in gene expression in T1 alpha null lung: A model of deficient alveolar sac development. BMC Dev Biol 2006;6: 35.
31. Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008;294: L152-L160.
32. Chua F, Gauldie J, Laurent GJ. Pulmonary fibrosis: Searching for model answers. Am J Respir Cell Mol Biol 2005;33: 9-13.
33. Chan EM, Ratanasirintrawoot S, Park IH et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 2009;27: 1033-1037.
34. Sridharan R, Tchieu J, Mason MJ et al. Role of the murine reprogramming factors in the induction of pluripotency. Cell 2009;136: 364-377.
35. Rippon HJ, Polak JM, Qin M et al. Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a novel three-step differentiation protocol. Stem Cells 2006;24: 1389-1398.
36. Roszell B, Mondrinos MJ, Seaton A et al. Efficient derivation of alveolar type II cells from embryonic stem cells for in vivo application. Tissue Eng Part A 2009;15: 3351-3365.
37. Stefanie Z, Peter B, Heimo M. Co-culture of alveolar epithelial, endothelial cells blunts failure of alveolar barrier function in hypoxia. The FASEB 2008;22: 932.8-932.
38. Wendt CH, Polunovsky VA, Peterson MS et al. Alveolar epithelial cells regulate the induction of endothelial cell apoptosis. Am J Physiol 1994;267(4 pt 1): C893-C900.